Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Increased Levels of Histone in Human Plasma in Septic Patients with DIC

Kazuo Kawasugi, MD PhD, Tadashi Yamamoto, MD, Naoki Shirafuji, MD PhD, Shingo Yamada, PhD, Ito Takashi, MD PhD, Ikuro Maruyama, MD PhD

Blood (2015) 126 (23): 1104.

https://doi.org/10.1182/blood.V126.23.1104.1104

Published: 2015

Journal Articles

Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial.

Hidehiko Saito, MD, Ikuro Maruyama, MD, Shuji Shimazaki, MD, Yasuhiro Yamamoto, MD, Naoki Aikawa, MD, FACS, Ryuzo Ohno, MD, Akio Hirayama, MD, Tamotsu Matsuda, MD, Hidesaku Asakura, MD, Mitsuyoshi Nakashima, MD, Nobuo Aoki, MD

Blood (2006) 108 (11): 576.

https://doi.org/10.1182/blood.V108.11.576.576

Published: 2006

Journal Articles

HMGB1 Derived from Macrophages Acts as an Angiogenic Factor.

Ikuro Maruyama, MD, PhD, Ko-ichi Kawahara, PHD, Takashi Ito, MD, Yoko Oyama, MD, Kazunori Takenouchi, MD, Toshiaki Shimizu, MD, Kiyoshi Kikuchi, MD, Teruto Hashiguchi, MD, PHD

Blood (2006) 108 (11): 3852.

https://doi.org/10.1182/blood.V108.11.3852.3852

Published: 2006

Journal Articles

Dynamic Defense System Against HMGB1, a Proinflammatory and Lethal Mediator in Severe Infections and Malignancies.

Takashi Ito, MD, Kazuhiro Abeyama, MD PhD, Ko-ichi Kawahara, PhD, Kamal K. Biswas, Tomonori Uchimura, MD PhD, Shingo Yamada, PhD, Teruto Hashiguchi, MD PhD, Ikuro Maruyama, MD PhD

Blood (2004) 104 (11): 3827.

https://doi.org/10.1182/blood.V104.11.3827.3827

Published: 2004

Journal Articles

The N-Terminal Domain of Thrombomodulin Sequesters HMGB1: A Novel Anti-Inflammatory Mechanism.

Kazuhiro Abeyama, MD. PhD., Yasushi Yoshimoto, PhD, Ikuro Maruyama, MD. PhD.

Blood (2004) 104 (11): 3435.

https://doi.org/10.1182/blood.V104.11.3435.3435

Published: 2004

Journal Articles

Uric Acid Induces High Mobility Group Box1 Protein Release in Monocytes/Macrophages through P38 MAPK, ERK1/2, JNK and AP-1 Activation.

Kamal K. Biswas, PhD, Yoko Oyama, MD, Kazuhiro Abeyama, MD, PhD, Teruto Hashiguchi, MD, PhD, Ikuro Maruyama, MD, PhD

Blood (2004) 104 (11): 1464.

https://doi.org/10.1182/blood.V104.11.1464.1464

Published: 2004

NARROW

Increased Levels of Histone in Human Plasma in Septic Patients with DIC

Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial.

HMGB1 Derived from Macrophages Acts as an Angiogenic Factor.

Dynamic Defense System Against HMGB1, a Proinflammatory and Lethal Mediator in Severe Infections and Malignancies.

The N-Terminal Domain of Thrombomodulin Sequesters HMGB1: A Novel Anti-Inflammatory Mechanism.

Uric Acid Induces High Mobility Group Box1 Protein Release in Monocytes/Macrophages through P38 MAPK, ERK1/2, JNK and AP-1 Activation.

Email alerts

ASH Publications

American Society of Hematology

Increased Levels of Histone in Human Plasma in Septic Patients with DIC

Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial.

HMGB1 Derived from Macrophages Acts as an Angiogenic Factor.

Dynamic Defense System Against HMGB1, a Proinflammatory and Lethal Mediator in Severe Infections and Malignancies.

The N-Terminal Domain of Thrombomodulin Sequesters HMGB1: A Novel Anti-Inflammatory Mechanism.

Uric Acid Induces High Mobility Group Box1 Protein Release in Monocytes/Macrophages through P38 MAPK, ERK1/2, JNK and AP-1 Activation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only